SACCENTI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 4.080
AS - Asia 1.877
EU - Europa 1.539
SA - Sud America 227
AF - Africa 24
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.755
Nazione #
US - Stati Uniti d'America 3.987
SG - Singapore 787
CN - Cina 568
IT - Italia 315
DE - Germania 306
PL - Polonia 240
BR - Brasile 186
GB - Regno Unito 158
TR - Turchia 140
HK - Hong Kong 133
FI - Finlandia 119
UA - Ucraina 112
VN - Vietnam 109
SE - Svezia 88
RU - Federazione Russa 52
CA - Canada 48
MX - Messico 39
BE - Belgio 38
ID - Indonesia 37
IN - India 27
FR - Francia 24
AR - Argentina 20
CZ - Repubblica Ceca 19
NL - Olanda 18
AT - Austria 12
BD - Bangladesh 12
ES - Italia 12
IQ - Iraq 12
JP - Giappone 11
LT - Lituania 10
ZA - Sudafrica 10
UZ - Uzbekistan 7
VE - Venezuela 5
AU - Australia 4
BO - Bolivia 4
IE - Irlanda 4
IR - Iran 4
PK - Pakistan 4
SA - Arabia Saudita 4
CL - Cile 3
DZ - Algeria 3
EC - Ecuador 3
KR - Corea 3
AL - Albania 2
CH - Svizzera 2
CO - Colombia 2
ET - Etiopia 2
HU - Ungheria 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
LK - Sri Lanka 2
MA - Marocco 2
MY - Malesia 2
PE - Perù 2
PH - Filippine 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
GD - Grenada 1
HN - Honduras 1
HR - Croazia 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MQ - Martinica 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
SN - Senegal 1
TL - Timor Orientale 1
TO - Tonga 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.755
Città #
Singapore 465
Ashburn 464
Woodbridge 405
Fairfield 387
Beijing 255
Ann Arbor 245
Chandler 238
Warsaw 237
Houston 187
Santa Clara 181
Seattle 169
Ferrara 144
Jacksonville 139
Wilmington 137
Munich 132
Hong Kong 131
New York 125
Cambridge 114
Dallas 109
Los Angeles 86
Izmir 60
Turku 54
Shanghai 51
Milan 45
Nanjing 44
Princeton 40
Brussels 38
Helsinki 36
Ho Chi Minh City 36
Addison 33
Jakarta 30
London 29
Bremen 28
São Paulo 28
Boardman 27
San Diego 25
Buffalo 23
Mexico City 22
Hanoi 21
Chicago 20
Denver 19
Shenyang 19
Stockholm 18
Brooklyn 17
Nanchang 17
Montreal 16
Poplar 16
Toronto 16
Phoenix 15
Tianjin 15
Changsha 14
Frankfurt am Main 13
Brno 12
Atlanta 11
Chennai 11
Orem 11
Rio de Janeiro 11
Rome 10
Council Bluffs 9
Dong Ket 9
Johannesburg 9
Manchester 9
Moscow 9
San Jose 9
Amsterdam 8
Bologna 8
Falls Church 8
Tampa 8
Tokyo 8
Boston 7
Hebei 7
Ningbo 7
Querétaro 7
Salt Lake City 7
Ankara 6
Haiphong 6
Hefei 6
Jinan 6
Kunming 6
Nuremberg 6
Olomouc 6
Providence 6
Redwood City 6
San Francisco 6
Vancouver 6
Da Nang 5
Falkenstein 5
Guarulhos 5
Jiaxing 5
Tashkent 5
The Dalles 5
Washington 5
Baghdad 4
Belo Horizonte 4
Buenos Aires 4
Cagliari 4
Des Moines 4
Dublin 4
Hangzhou 4
Monza 4
Totale 5.563
Nome #
Chronic lymphocytic leukemia: assessing pathogenesis and prognosis by modern molecular cytogenetic studies and microRNAs expression 282
Absolute quantification of cell-free microRNAs in cancer patients 280
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 265
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 262
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR 256
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 237
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 227
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 224
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 221
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 220
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 220
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 216
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 215
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 208
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 206
Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis 192
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia 190
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 189
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 189
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 189
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 187
REFINED KARYOTYPE-BASED PROGNOSTIC STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH A VERY LOW RISK GENETIC PROFILE 186
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 181
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 175
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 174
Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation 173
Clonal evolution in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 162
Quantification of circulating miRNAs by droplet digital PCR: Comparison of EvaGreen- and TaqMan-based chemistries 161
INTEGRATION OF NOVEL GENE MUTATIONS INTO KARYOTYPE-BASED SUBGROUPS AS A PROGNOSTIC RISK STRATIFICATION TOOL IN CHRONIC LYMPHOCYTIC LEUKEMIA 159
In chronic lymphocytic leukaemia, SLAMF1 deregulation is associated with genomic complexity and independently predicts a worse outcome 157
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 156
Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profile 153
DNA methylation of shelf, shore and open sea CpG positions distinguish high microsatellite instability from low or stable microsatellite status colon cancer stem cells 142
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 139
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 137
LATE APPEARANCE of 14q32/IGH TRANSLOCATION In CHRONIC LYMPHOCYTIC LEUKEMIA. 135
EFFICACY AND SAFETY PROFILE OF DASATINIB IN A SUBSET OF VERY ELDERLY PATIENS WITH CHRONIC MYELOID LEUKEMIA (CML) RESISTANT/INTOLERANT TO IMATINIB 126
Modern treatment in chronic lymphocytic leukemia: impact on survival and efficacy in high-risk subgroups. 125
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 120
Diagnostic workup for clinical and prognostic assessment of acute leukemia. 103
How to fish a good micro-marker out from a worthless lake: The case of cell-free miR-181a-5p and breast cancer 91
Additional lesions identified by genomic microarrays are associated with an inferior outcome in low-risk chronic lymphocytic leukaemia patients 88
null 77
null 64
Totale 7.859
Categoria #
all - tutte 36.135
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.135


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021518 0 0 0 0 0 72 50 71 17 123 123 62
2021/2022539 51 36 23 25 34 23 59 30 16 36 57 149
2022/2023524 56 55 23 75 89 66 36 35 53 1 23 12
2023/2024330 22 34 9 4 17 88 22 34 7 9 5 79
2024/20251.389 20 26 88 77 162 153 28 25 252 108 213 237
2025/20262.100 403 154 244 442 612 245 0 0 0 0 0 0
Totale 7.859